Open access
Aug 2026
The KAT8-CDK1 K33 acetylation axis drives doxorubicin resistance by suppressing ferroptosis and apoptosis in breast cancer
KAT8-dependent CDK1 K33 acetylation is established as a key epigenetic mechanism sustaining anthracycline resistance and targeting the KAT8-CDK1 axis may provide a therapeutic strategy to overcome refractory breast cancer.
Qing-Zhi Zhao, Qi-Xian Zou, Jin-Meng Chu et al.
· Cell Death and Disease · 0 citations